J.R. Sowers, “Obesity as a kardiovascular risk factor”, The Amecican Journal of Medicine, 2003; Vol 115, No 8 pp 37-41.

The World Health Report 2002 , Reducing Risks, Promoting Healthy Life,WHO, Geneva 2002.

N. Aoi, M. Soma, T. Nakayama, et al. “Variable number of tandem repeatof the 5-fl anking region of type C- human natriuretic peptid receptor gene infl uences bood pressure levels in obesity associated hypertension”, Hypertension research, 2004; Vol. 27, N

K.Kosuge, M. Soma, T. Nakayama, “Human uncapling protein 2 and 3 genes are associated with obesity in Japanese”, Endocrine, 2008; Vol. 34, No 1-3, pp 87-95.

K. Strohacker, B.K. Mc Farlin, “Infl uence of obesity, physical inactivity and weight cycling on chronic infl ammation”, Frontiers in Bioscience”,2004, Vol. 2, pp 98-104

V. De Clercq, C. Teylor, P. Zahradka, “Adipose tissue: The link between obesity and cardiovascular disease”,Cardiovascular and Hematological Disorders Drug Targets”, 2007; Vol.8, No3, pp 238-237.

S.K. Fried, D.A. Bunkin, A.s. Greenberg, “Omental and subcutaneous adipose tissue of obese subjects release interleukin 6: depot difference and regulationby glucocorticoid” The Journal of Clinical Endocrinology, 1998; Vol. 83, No 3, pp 843-850

Alma Ata 1978, Primary Health Care, WHO, Geneva, 1978

An Appeal on Behalf of Children and Adolescents in Europe, General Assembly of UNEPSA, Rome, 28.09.2006

Banićević M. Povelja za opštu praksu/porodičnu medicinu u Evropi – motivi i ciljevi. Bilten Instituta za zdravstvenu zaštitu majke i deteta Srbije, godina III br.9/10 str. 37-45, 1998

A Charter for General Practice / Family Medicine. Working draft. Copenhagen : WHO/EURO, 1995.

The European strategy for child and adolescent health and development, Copenhagen: WHO Regional Offi ce for Europe, 2005.